Gene that dramatically increases colorectal cancer risk uncoveredAugust 15th, 2008 - 2:04 pm ICT by ANI
Washington, August 15 (ANI): Northwestern University scientists in the U.S. claim to have discovered a major genetic trait which is present in 10 to 20 per cent of colorectal cancer patients, and appears to be the most common cause of the disease.
The researchers say that the trait, dubbed TGFBR1 ASE, increases an individuals lifetime risk of developing colorectal cancer is 50 per cent, compared to six per cent for the general population.
“This probably accounts for more colorectal cancers than all other gene mutations discovered thus far,” said Dr. Boris Pasche, director of the Cancer Genetics Program at the universitys Feinberg School of Medicine.
“The reasonable expectation is this finding will save some lives. We will be able to identify a larger number of individuals that are at risk of colorectal cancer and, in the long term, maybe decrease the cases of colorectal cancer and of people dying from it by being able to screen them more frequently,” added Pasche, who is a lead author of the paper published in the online edition of the journal Science.
The researchers say that the trait results in decreased production of a key receptor for TGF-beta, the most potent inhibitor of cell growth.
With less of this vital protective substance to inhibit cell growth, colon cancer can more easily develop.
This is the first time that a study has shown that decreased production of this receptor for TGF-beta was present in 10 to 20 per cent of colorectal cancer patients.
Decreased production of the same receptor was present in only one to three per cent in healthy control groups.
Pasche said revealed that the findings were based on a Caucasian population, and insisted that they needed to be confirmed in other studies.
The researcher expects that a clinical test will soon be developed that could be offered to families with a history of colorectal cancer, and other individuals to determine whether they carry this mutation. (ANI)
- Gene behind rare skin cancer that heals itself discovered - Mar 11, 2011
- Anti-hypertensive drug improves multiple sclerosis-related brain inflammation - Jul 29, 2010
- Blocking action of protein blunts serious ill effects of high BP on heart - May 03, 2011
- Genetic fault that causes rare self-healing skin cancer identified - Feb 28, 2011
- NSAIDs prevent colon cancer by causing stem cells to self-destruct - Nov 02, 2010
- Full genetic blueprint of blood cancer offers new insights - Mar 24, 2011
- Scientists isolate gene in self-healing skin cancer - Feb 28, 2011
- Normal healthy breast cells can help kill cancer cells - Apr 14, 2011
- Intestinal stem cells offer clues to colon cancer origin and relapse - Mar 18, 2011
- Genetic variants that modify breast cancer risk identified - Sep 20, 2010
- FDA approves personalized therapy for tough-to-treat colorectal cancer - Jul 26, 2012
- Humpty Dumpty-like chromosomes trigger cancer quicker than usual - Jan 17, 2011
- 'Low oxygen levels drive cancer growth' - May 06, 2012
- Scientists complete whole-exome sequencing of skin cancer - Apr 16, 2011
- Study finds gene mutation strongly linked to schizophrenia - Feb 03, 2011
Tags: august 15, cancer genetics program, cancer risk, caucasian population, clinical test, colon cancer, colorectal, colorectal cancer patients, colorectal cancers, control groups, feinberg school of medicine, gene mutations, genetic trait, journal science, lifetime risk, northwestern university, pasche, potent inhibitor, school of medicine, university scientists